10. Change from baseline in SGRQ: included studies.
Study | Endpoint (weeks) | Treatments compared | Mean difference vs Placebo | SE of Mean difference | |||||
Albert 2011 | 52 | Placebo | AZM 250 mg once daily | ‐2.2 | 0.7853 | ||||
Berkhof 2013 | 12 | Placebo | AZM250 mg once daily 3 times per week | ‐7.5 | 2.5456 | ||||
He 2010 | 26 | Placebo | ERY 125 mg 3 times daily | ‐3 | 5.6801 | ||||
Sethi 2010 | 48 | Placebo | MOX 400 mg once daily (5 days every 8 weeks) | ‐1.2 | 0.9231 | ||||
Simpson 2014 | 12 | Placebo | AZM 250 mg once daily | 6.1 | 5.31927 | ||||
Uzun 2014 | 52 | Placebo | AZM500 mg once daily 3 times per week | ‐0.61 | 2.622449 | ||||
Brill 2015* | 13 | Placebo | a. DOX 100 mg once daily b. AZM 250 mg once daily 3 times per week c. MOX 400 mg once daily (5 days every 4 weeks) |
a. 1.02 | b. ‐2.29 | c. ‐1.88 | a. 3.135 | b. 3.212 | c. 3.426 |
a. 0.88 | b. ‐2.35 | c. ‐2.25 | a. 3.132 | b. 3.085 | c. 3.233 |
Abbreviations
AZM: azithromycin; DOX: doxycycline; ERY: erythromycin; MOX: moxifloxacin; SE: standard error; SGRQ: St George's Respiratory Questionnaire.
*Data in bold used in sensitivity analysis.